l General Information |
Product Name | Cidofovir dihydrate |
General description | Cidofovir is a Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor. |
Synonym | [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid; dehydrate; Cidofovir hydrate |
Purity | ≥99.0%(HPLC) | CAS Number | 149394-66-1 |
Formula | C8H18N3O8P | Molecular Weight | 315.219 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ~2mg/mL |
Ethanol | Insolube |
Water | ≥10mg/mL |
l Biological Information |
Biochem/Physiol
Actions | Cidofovir is a new anti-viral drug. It is classified as a nucleotide analogue and is active against herpes cytomegalovirus (CMV) retinitis infection. Most adults are infected with CMV. Cidofovir suppresses cytomegalovirus (CMV) replication by selective inhibition of viral DNA synthesis. |
Application | Antiviral Agents |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This
product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
